Skip to main navigation Skip to search Skip to main content

Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction

  • Mike J.P. De Jong*
  • , Foke Van Delft
  • , Erwin Jan M. Van Geenen
  • , Auke Bogte
  • , Robert C. Verdonk
  • , Niels G. Venneman
  • , Jan Maarten Vrolijk
  • , Jan Willem A. Straathof
  • , Rogier P. Voermans
  • , Rina A. Bijlsma
  • , Sjoerd D. Kuiken
  • , Rutger Quispel
  • , Muhammed Hadithi
  • , Kirill Basiliya
  • , Frank P. Vleggaar
  • , Tanya M. Bisseling
  • , Thomas R. De Wijkerslooth
  • , Marco J. Bruno
  • , Roy L.J. Van Wanrooij
  • , Peter D. Siersema
  • *Corresponding author for this work
  • Radboud University Medical Center
  • St. Antonius Ziekenhuis
  • Utrecht University
  • Medisch Spectrum Twente
  • Rijnstate Hospital
  • Maxima Medical Centre
  • University of Amsterdam
  • Martini Ziekenhuis
  • Onze Lieve Vrouwe Gasthuis
  • Renier de Graaf Gasthuis
  • Maasstad Hospital
  • Leiden University
  • Netherlands Cancer Institute
  • VU University Medical Center

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)
4 Downloads (Pure)

Abstract

Background:

Percutaneous transhepatic biliary drainage (PTBD) and endoscopic ultrasound-guided biliary drainage (EUS-BD), including choledochoduodenostomy (EUS-CDS), are alternative methods for biliary drainage in patients with distal malignant biliary obstruction (MBO) after failed endoscopic retrograde cholangiopancreatography (ERCP). Data on long-term outcomes, adverse events (AEs), and quality of life (QoL) after EUS-CDS and PTBD are limited. Therefore, we created a registry to evaluate the outcomes of both drainage procedures. 

Methods:

Patients with distal MBO who underwent EUS CDS or PTBD after unsuccessful ERCP were included in this multicenter investigator-initiated prospective registry over an 18-month inclusion period. Primary end points were procedure-related AEs and mortality within 90 days post procedure. Secondary end points included technical and clinical success, reinterventions, hospital stay, and QoL. 

Results:

55patients wereincluded, with 12patients under going PTBD (technical success 100%) and 43 patients EUS CDS (technical success 97.7%). Prior to ERCP, 7/12 patients in the PTBDgroupand12/43patientsintheEUS-CDSgroup opted for best supportive care. The 90-day mortality rate was 66.7% in the PTBD group and 20.9% in the EUS-CDS group (P=0.005). Furthermore, 11/12 patients (91.7%) in the PTBD group and 19/43 (44.2%) in the EUS-CDS group developed one or more AEs (P=0.004). The median post procedural hospital stay was 4 days (interquartile range [IQR] 2-6) in the PTBD group vs. 1 day (IQR 1-2) in the EUS-CDS group (P=0.001). 

Conclusion:

When both modalities were available and technically feasible, gastroenterologists preferred EUS-CDS over PTBD. EUS-CDS seems to be associated with lower mortality and AErates, shorter hospital admission, and few er reinterventions, but a randomized controlled trial should confirm these observations.

Original languageEnglish
Pages (from-to)1004-1015
Number of pages12
JournalEndoscopy
Volume57
Issue number9
DOIs
Publication statusPublished - 28 Aug 2025

Bibliographical note

Publisher Copyright:
© 2025. The Author(s).

Fingerprint

Dive into the research topics of 'Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction'. Together they form a unique fingerprint.

Cite this